CV-6209, A HIGHLY POTENT ANTAGONIST OF PLATELET-ACTIVATING-FACTOR INVITRO AND INVIVO

被引：0
|
作者：
TERASHITA, ZI
IMURA, Y
TAKATANI, M
TSUSHIMA, S
NISHIKAWA, K
机构：
[1] TAKEDA CHEM IND LTD,DIV CENT,BIOL LABS,YODOGAWA KU,OSAKA 532,JAPAN
[2] TAKEDA CHEM IND LTD,DIV CENT,CHEM LABS,YODOGAWA KU,OSAKA 532,JAPAN
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1987年 / 242卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：263 / 268
页数：6
相关论文
共 50 条
  • [1] PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS - DEVELOPMENT OF THE POTENT PAF ANTAGONIST, CV-6209
    TAKATANI, M
    YOSHIOKA, Y
    TASAKA, A
    TERASHITA, Z
    NISHIKAWA, K
    TSUSHIMA, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S174 - S174
  • [2] EFFECTS OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST, CV-6209, ON GASTRIC-MUCOSAL LESIONS INDUCED BY ISCHEMIA-REPERFUSION
    YOSHIKAWA, T
    TAKAHASHI, S
    NAITO, Y
    UEDA, S
    TANIGAWA, T
    YOSHIDA, N
    KONDO, M
    LIPIDS, 1992, 27 (12) : 1058 - 1060
  • [3] A New Platelet-Activating Factor Antagonist (CV-6209) in Preservation of Heart and Lung for Transplantation
    Karim A. Qayumi
    John C. English
    Elizabeth J.E. Feeley
    Ahmed Poostizadeh
    Maryam Nikbakht-Sangari
    Cardiovascular Drugs and Therapy, 1997, 11 : 777 - 785
  • [4] A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation
    Qayumi, KA
    English, JC
    Feeley, EJE
    Poostizadeh, A
    Nikbakht-Sangari, M
    CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (06) : 777 - 785
  • [5] EFFECTS OF THE PLATELET-ACTIVATING-FACTOR ANTAGONISTS CV-6209 AND CV-3988 ON NEPHROTOXIC SERUM NEPHRITIS IN THE RAT
    IIDA, H
    FUJITA, M
    IZUMINO, K
    ASAKA, M
    ENTANI, C
    TAKATA, M
    SASAYAMA, S
    NEPHRON, 1992, 60 (04): : 471 - 476
  • [6] Anti-Helicobacter pylori actions of CV-6209, a platelet-activating factor receptor antagonist
    Iwao, Yasuhisa
    Takano, Tomomi
    Taneike, Ikue
    Reva, Ivan
    Isobe, Hirokazu
    Zhang, Hui-Min
    Nishiyama, Akihito
    Yamamoto, Tatsuo
    JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, 2013, 59 (02): : 147 - 152
  • [7] TRIAZOLODIAZEPINES ARE POTENT ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR (PAF) INVITRO AND INVIVO
    CASALSSTENZEL, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (03) : 351 - 355
  • [8] INHIBITION OF NEUTROPHIL RESPIRATORY BURST AND DEGRANULATION RESPONSES TO PLATELET-ACTIVATING-FACTOR BY ANTAGONISTS WEB-2086, CV-6209 AND CV-3988
    BATES, EJ
    HARVEY, DP
    FERRANTE, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 97 (01) : 50 - 56
  • [9] PLATELET-ACTIVATING-FACTOR-INDUCED CHANGES IN CARDIOVASCULAR FUNCTION AND OXYRADICAL STATUS OF MYOCARDIUM IN PRESENCE OF THE PAF ANTAGONIST CV-6209
    GUPTA, JB
    PRASAD, M
    KALRA, J
    PRASAD, K
    ANGIOLOGY, 1994, 45 (01) : 25 - 36
  • [10] CV-6209 IS A NON-COMPETITIVE ANTAGONIST OF PLATELET-ACTIVATING FACTOR RECEPTORS ON GUINEA-PIG RESIDENT PERITONEAL-MACROPHAGES
    STEWART, AG
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (11) : 813 - 820
12345